Preparation method of terlipressin impurity Q

A technology of terlipressin and impurities, which is applied in the field of preparation of terlipressin impurity Q, and can solve the problems of not preparing impurity Q, etc.
CN114685613APending Publication Date: 2022-07-01HYBIO PHARMA

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HYBIO PHARMA
Publication Date
2022-07-01

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the technical field of polypeptide synthesis, in particular to a preparation method of a terlipressin impurity Q. The preparation method comprises the following steps: firstly synthesizing a polypeptide fragment I and a polypeptide fragment II which are good in stability, then carrying out disulfide bond exchange on SH of a fourth Cys residue at the C end of the polypeptide fragment I and SNpys or SPyr of the fourth Cys residue at the C end of the polypeptide fragment II through condensation reaction to form a first pair of disulfide bonds, and carrying out iodine oxidation reaction to form a second pair of disulfide bonds while removing an Acm protecting group of the Cys. Experiments show that the terlipressin impurity Q obtained by the preparation method is high in purity and few in impurity, and the purity of a crude product can reach 75% or above.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of polypeptide synthesis, in particular to a preparation method of terlipressin impurity Q. Background technique

[0002] Terlipressin is a synthetic analog of a hormone secreted by the posterior pituitary gland. It can be hydrolyzed by enzymes in the human body to generate vasopressin, which has a contracting effect on smooth muscle. It is mainly used clinically to treat esophageal varices bleeding. Its peptide sequence is as follows:

[0003]

[0004] Terlipressin can generate impurities Q during the preparation and storage process, which can affect the safety of the drug. In the process of developing the terlipressin production process, it is necessary to prepare a reference substance of impurity Q for the study of its product quality.

[0005] The peptide sequence of impurity Q is as follows:

[0006]

[0007] At present, a large number of literatures in the prior art report the preparation met...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More